|
Generic Name : Tesamorelin
Pronunciation : TES-a-moe-REL-in
Trade Name(s):
International- Egrifta. This medication is a human growth hormone-releasing factor (GRF) analog, prescribed for reducing excess stomach fat in certain HIV-infected patients. When it is not to be taken (Contraindications):
When it is to be taken : SC- The recommended dose is 2 mg once a day. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider under the skin. Special Instruction : * Caution should be exercised in patients with history of severe breathing problem, complications from surgery, injury, kidney or liver disease, cancer, non-cancerous growths, sugar, any allergy, who are taking other medications, during pregnancy and breastfeeding. * It may raise blood sugar level; monitor sugar level regularly while taking this medication. * It should not be used in children. Side Effects : Musculoskeletal - Joint pain, pain in extremity, muscle pain, muscle stiffness, muscle strain, joint stiffness, muscle spasms and joint swelling. General - Injection site redness, itching, pain, irritation, bleeding, hives, swelling and chest pain. Central Nervous system - Tingling, sensory loss, depression, and nerve pain in wrist. Gastrointestinal - Nausea, vomiting, indigestion, and abdominal pain. Heart - Palpitations, and high blood pressure. Skin - Rash, itching and night sweats. * Avoid excess dosage. Storage Conditions : Store it at controlled room temperature (20 to 25°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||


